Table V-IIHead and Neck Cancer. Patient Characteristics

StudyAge% FemaleRace (%)Disease StagePerformance StatusComorbidities or Other Prognostic Factors
24520, Nagler et al., 2003Grp1Grp1Grp1Grp1ScaleGrp1Tumor GradeGrp1
mn5645Jews97Ia
mdArabs3Ib
rng15–79IIa
sd4IIb
>6045%IIIa
IIIb
IV
25490, Khan et al., 2002Grp1Grp1Grp1Grp1ScaleGrp1Tumor GradeGrp1
mn18B16T1–234
mdW84T3–466
rngHN018
sdAN143
ON2–339
41–5625%II9
56–5925%III28
59–6625%IV63
66–7925%

From: Appendix C. Evidence Data Abstraction Tables

Cover of HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors
HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors.
Evidence Reports/Technology Assessments, No. 172.
Seidenfeld J, Samson DJ, Rothenberg BM, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.